Nonsteroidal Topical Gets FDA Approval for Psoriasis
![](https://jdnppa.com/wp-content/uploads/2022/08/psoriasis-shutterstock_453338494-1024x683.jpg)
A new nonsteroidal agent, tapinarof cream 1%, is approved for adults with plaque psoriasis based on studies showing a high degree of efficacy and minimal risk of adverse events with daily use. New Drugs: Tapinarof Cream By Ted Rosen, MD Tapinarof Cream 1% (Vtama, Dermavant) was recently FDA approved to treat mild, moderate, or severe plaque […]